[State of the hemostasis system and pathogenetic therapy of circulatory encephalopathy].
Bekuzarova
M R
MR
Burd
G S
GS
Kolesnikova
T I
TI
Iasamanova
A N
AN
Kabanov
A A
AA
D000328:Adult; D000367:Age Factors; D000368:Aged; D001549:Benzamides / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000097:blood / Q000209:etiology / Q000628:therapy*; D004338:Drug Combinations; D005340:Fibrinogen / Q000032:analysis; D006487:Hemostasis; D006592:Hexobendine / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000627:therapeutic use*; D010889:Piracetam / Q000627:therapeutic use*; D010974:Platelet Aggregation; D013806:Theophylline / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D001549:Benzamides; D000697:Central Nervous System Stimulants; D004338:Drug Combinations; D018696:Neuroprotective Agents; D018697:Nootropic Agents; C001453:Instenon; D005340:Fibrinogen; D006592:Hexobendine; D013806:Theophylline; D010889:Piracetam
Sostoianie sistemy gemostaza i patogeneticheskaia terapiia pozdnikh stadiĭ distsirkuliatornoĭ éntsefalopatii..